Boehringer Ingelheim increases commitments to sustainable development, investing in health innovation and collaborations to expand access and improve healthcare for 50 million people in vulnerable communities by 2030

Ingelheim, 25 October 2021 – Today, on the occasion of the World Health Summit 2021, Boehringer Ingelheim shares an update on its strategic approach to sustainable development. A commitment to initiatives that contribute to ‘More Health’, one of the three pillars within the company’s ‘Sustainable Development - For Generations’ framework. 

Continuing a journey that began more than 135 years ago, Boehringer Ingelheim is building on its track record in addressing unmet health needs, increasing the company’s ambitions to tackle global health challenges. The strategic approach also focuses on the strength and value of collaboration and long-term partnerships to contribute towards achieving a healthier and more sustainable future for society.

• Expanding NCD healthcare access for 50 million people in vulnerable communities
• Investing EUR 250 million in partnerships and collaborations to combat infectious diseases in human and animal health 
• Increased investment in health innovation to EUR 35 billion to tackle non-communicable diseases (NCDs) by 2030 
• Supporting initiatives to alleviate significant challenges such as tackling rabies and African Animal Sleeping Sickness, as well as advancing parasitology, aiming at continuously integrating efficacy and environmental aspects 

• Patient assistance and product donation initiatives have reached over 150,000 patients worldwide, across 77 countries on all continents
• The Angels Initiative, committed to expanding the network of stroke centers and stroke-ready hospitals, has enrolled over 5,400 hospitals that have served 8.6 million patients to date with substantially improved care
• The Kuza Afya program in Kenya, a diabetes and hypertension care program, has screened approximately 79,000 people for these diseases, trained over 500 healthcare professionals and offered a path to treatment for over 5,000 previously unserved patients
• In 2019, an initiative was launched in partnership with PharmAccess, a non-profit organization that works to improve access to quality healthcare in Africa, to leverage mobile technology in Kenya to address awareness and access barriers in hypertension and diabetes
• The ‘Pathway’ health project fund in Canada will impact the lives of over 20,000 people, addressing the excessive prevalence of certain NCDs in indigenous communities
• The Last Mile initiative, stretching across six countries in sub-Saharan Africa, has reached over 7,000 smallholder farmers, training them in leveraging access to healthcare solutions, vaccines and treatments to optimize the health and productivity of their livestock
• In 2020 a new pilot program was launched in Pakistan in collaboration with the World Organization for Animal Health (OIE) to eliminate rabies by donating Boehringer Ingelheim’s vaccine, Rabisin®, and collars which help to identify vaccinated dogs